查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球气管插管市场
市场调查报告书
商品编码
1153800

2022-2029 年全球气管插管市场

Global Endotracheal Tube Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期内（2022 年至 2029 年），气管插管的全球市场规模预计将以 6.00% 的复合年增长率增长。

气管插管是一种柔性塑料管，通过口腔进入气管，气管与呼吸机相连，为肺部供氧。当患者无法自行呼吸时，会插入气管插管。插入管子的过程称为气管插管。气管插管大多由聚氯乙烯 (PVC) 製成，并且只能一次性使用。

市场动态

全球气管插管市场主要受肺栓塞、慢性阻塞性肺病等呼吸系统疾病发病率增加、手术过程中麻醉活动次数增多、麻醉首选喉罩优于 ETT 的趋势上升、术中插管需求增加所推动重伤和全球手术数量的增加是预测期内推动市场的因素。

慢性呼吸道疾病患病率的增加预计将推动市场增长。

根据美国疾病控制与预防中心的数据，慢性呼吸道疾病 (CRD) 会损害气道和其他肺部结构。慢性阻塞性肺病 (COPD)、哮喘、职业性肺病和肺动脉高压是最常见的疾病。除了烟草烟雾，空气污染、职业化学品和粉尘以及儿童期反復发作的下呼吸道疾病也是危险因素。哮喘影响全球约3亿人，在美国等发达国家更为普遍。

此外，根据 CDC 的 2020 年全国健康访谈调查 (NHIS)，估计美国有 2520 万成年人（包括 420 万儿童）患有哮喘。 2020 年，包括约 180 万儿童在内的超过 1030 万哮喘患者报告至少发生过一次哮喘发作。因此，伴有急性呼吸困难的哮喘患者首选气管插管。因此，从上述描述来看，它有望成为市场增长的引擎。

缺乏熟练的气管插管专业人员预计会阻碍市场增长。

气管插管手术需要高技能的麻醉师和训练有素的护士。缺乏关于正确选择立即治疗的知识会对患者状况产生不利影响，增加恢復时间，并增加直接和间接成本。在紧急情况下，严重损伤的诊断和处理不当会导致受伤部位畸形、功能障碍，甚至导致患者死亡。据世界卫生组织称，估计约有 70% 的慢性阻塞性肺病患者由于对该病缺乏认识而未被确诊。此外，与慢性阻塞性肺病一样，哮喘未得到充分诊断和治疗（约 50% 的哮喘患者）。这些因素阻碍了预测期内的市场增长。

此外，麻醉师和护理人员的短缺是世界各国关注的主要问题之一。这种短缺直接影响医疗机构提供外科和急救护理的效率和能力，进一步阻碍了对这些手术中使用的气管插管设备的需求。

COVID-19 影响分析

COVID-19 疫情对气管插管行业产生了积极影响。由于呼吸窘迫是感染的明确指标，COVID-19 的出现显着增加了对气管插管的需求，推动了市场的增长。对于 COVID 患者的呼吸衰竭，美国支气管和介入医学学会建议进行开放式外科气管切开术 (OST) 或经皮扩张气管切开术。此外，大流行为紧急产品批准铺平了道路。例如，总部位于美国的生物技术公司 N8 已获得加拿大卫生部的批准，可以紧急使用 Therashield 气管导管对 COVID-19 患者进行机械通气。此外，据说大型私立和公立医院的呼吸设备引进率相对较高，而小型医院和诊所的引进率较低。基于上述情况，市场有望在预测期内活跃起来。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 由于慢性呼吸道疾病的增加，预计该市场将会扩大。
    • 约束因素
      • 缺乏精通气管插管的专业人员预计会阻碍市场增长。
    • 机会
    • 影响分析

第五章行业分析

  • 搬运工的五种力量
  • 供应链
  • 定价分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 普通气管插管（标准管）
  • 加强型/铠装气管插管
  • 预製气管插管
  • RAE 管
  • 双腔气管插管
  • 其他特殊气管插管
      • 微型喉气管插管
      • 激光气管插管
      • 其他（声门下抽吸气管插管）

第 8 章插管类型

  • 气管插管
  • 鼻气管

第 9 章按应用

  • 治疗
  • 紧急处理
  • 其他

第 10 章最终用户

  • 医院
  • 专科诊所
  • 门诊手术中心
  • 其他

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第13章公司简介

  • ConvaTec Inc.
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Bactiguard AB
  • Teleflex Incorporated
  • Medtronic Plc.（Covidien）
  • Smith's Group plc.（Smiths Medical）
  • ROYAX, S.R.O
  • Medline Industries, Inc.
  • Eakin Healthcare Group（Armstrong Medical Ltd）
  • Venner Medical
  • P3 Medical Limited

第14章 世界气管插管-DataM

简介目录
Product Code: DMMD1149

Market Overview

The global endotracheal tube size was valued US$ YY million in 2021 and is expected to reach US$ YY million by 2029, growing at a CAGR of 6.00% during the forecast period (2022-2029).

An endotracheal tube is a flexible plastic tube that is placed through the mouth into the trachea which is connected to a ventilator to deliver oxygen to the lungs. The tube is inserted when a patient is unable to breathe on their own. The process of inserting the tube is called endotracheal intubation. Endotracheal tubes are mostly made of polyvinyl chloride (PVC) and can be used only once.

Market Dynamics

The global endotracheal tube market is primarily driven by the increasing incidence of respiratory diseases such as pulmonary embolism, chronic obstructive pulmonary disorders and number of anesthesia activity during surgeries, etc., growing preference for anesthesia laryngeal masks over ETTs, increasing need for intubation during severe injuries, and rising surgeries across the globe are the factors to drive the market in the forecast period.

The increasing prevalence of chronic respiratory diseases is expected to drive market growth.

According to the Centers for Disease Control and Prevention, chronic respiratory disorders (CRDs) impair the airways and other lung structures. Chronic obstructive pulmonary disease (COPD), asthma, occupational lung disorders, and pulmonary hypertension are some of the most frequent. Air pollution, occupational chemicals and dust, and repeated lower respiratory illnesses during childhood are also risk factors in addition to tobacco smoke. Asthma affects around 300 million individuals worldwide, which is more prevalent in industrialized countries such as the United States.

Additionally, according to the CDC's 2020 National Health Interview Surveys (NHIS), an estimated 25.2 million adults, including 4.2 million children, have asthma in the United States. In 2020, more than 10.3 million asthmatics, including approximately 1.8 million children, reported having one or more asthma attacks. Therefore, orotracheal intubation is preferred for asthmatic patients in acute respiratory distress. Thus, from the above statements, the market is expected to drive market growth.

The lack of skilled professionals for endotracheal intubation is expected to hamper the market growth.

Endotracheal tube procedures require highly skilled anesthetists and trained nurses. The lack of knowledge regarding the right choice of immediate treatment can adversely affect the patient's condition, increase recovery time, and surge direct and indirect expenses. In emergency conditions, the improper diagnosis and treatment of serious injuries can cause deformities and lead to the dysfunction of the injured area or patient death. According to the WHO, it is estimated that around 70% of COPD patients are underdiagnosed owing to the lack of awareness about the disease. Like COPD, asthma is also highly underdiagnosed and undertreated (in around 50% of asthmatics). Thus these factors are hampering the market growth in the forecast period.

Moreover, the shortage of anesthetists and paramedics has become one of the key concerns for countries across the globe. The shortage has directly impacted the efficiency and capabilities of healthcare settings to provide surgical and emergency care, further hampering the demand for endotracheal tube devices used across these procedures.

COVID-19 Impact Analysis

The COVID-19 epidemic had a positive impact on the endotracheal tube industry. The advent of COVID-19 has significantly increased the demand for endotracheal tubes, as breathing trouble is a clear indicator of infection, which has driven market growth. In the event of respiratory failure in COVID patients, the American Association for Bronchology and Interventional Pulmonology recommends conducting Open Surgical Tracheostomy (OST) or percutaneous dilatational tracheostomy. Moreover, the pandemic paved the way for emergency product approvals. For instance, a U.S.-based biotech firm, N8, secured emergency use authorization from Health Canada For its CeraSheild Endotracheal Tubes in mechanically ventilated COVID-19 patients. In addition, large private and public hospitals relatively have higher uptake of respiratory devices, and small hospitals and clinics have a low rate of product uptake. Thus, from the above statements, the market got driven in the forecast period.

Segment Analysis

Ambulatory surgical centers (ASCs) segment is expected to hold the largest market share in endotracheal tube

The ambulatory surgical centers (ASCs) segment accounted for the largest market share in 2021. With rapid technological advancements in the healthcare sector, 60% of all surgeries can be performed at ambulatory surgical units, creating a surging demand for surgical procedures in emerging economies such as India. ASCs are expected to reduce the average cost of treatment by 70% when compared to the cost of inpatient surgery. This factor is important for a country like India, with 1.4 billion population, in which a significant number of people can earn less than $ 2 a day. Moreover, many Central government policies under the Ministry of Ayush facilitate people under the poverty line by providing them with medical insurance.

Additionally, in the U.S., Medicare is the largest single-payer of clinical services. Medicare spending accounts for more than 40% of the clinical expenditures of patients. Medicaid payments are divided into three main categories, the traditional home health benefit (mandatory), the personal healthcare option, and home and community-based waivers as an optional program. These three healthcare service categories collectively hold a small share of total Medicaid payments. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global endotracheal tube

North America region accounted for the largest market share in 2021. Over 40 million endotracheal intubations are performed annually in the U.S., making it the single largest interventional procedure. Nearly 2 million of those procedures are complex and challenging to perform. The LightSpeed Intubation System enables quicker and safer positioning of the endotracheal tube without losing control of the airway. Due to the high number of such cases, the demand for airway management devices is increasing globally.

Moreover, the presence of major regional players contributed to market growth. For instance, on January 14, 2020, Smiths Medical launched a new Polyvinyl Chloride (PVC) tracheostomy tube portfolio to its family of tracheostomy tubes. Smith's Medical BLUselect tracheotomy tubes, BLUperc and BLUgriggs percutaneous tracheostomy kits and trays. Additionally, many players in the market are developing products with antimicrobial and anti-coagulant coating properties that can reduce VAP. For instance, Medtronic Shiley Evac endotracheal tubes have been stated to reduce VAP by 50.0%. Thus, from the above statements, the North American region accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the endotracheal tube are: ConvaTec Inc., Bactiguard AB, Teleflex Incorporated, Medtronic Plc. (Covidien), Smiths Group plc.(Smiths Medical), ROYAX, S.R.O, Medline Industries, Inc., Eakin Healthcare Group(Armstrong Medical Ltd), Venner Medical and P3 Medical Limited

In January 20, 2022, P3 Medical is set to showcase a device designed to tighten infection control in airway management at Arab Health 2022. The NeVap Aspire Subglottic Suction Endotracheal tube (ASSET) is the only FDA-cleared multiport suction breathing tube. Clinicians have developed it to make mechanical ventilation safer by preventing the risks of ventilator-associated pneumonia.

Covidien:

Overview:

Covidien was an Irish-headquartered global healthcare product company and manufacturer of medical devices and supplies. Covidien became an independent publicly traded company after being spun off from Tyco International in 2007. Covidien's portfolio consists of medical devices, including surgical, respiratory, patient monitoring, gastrointestinal, lung health, and renal care products. The Medical Devices segment includes developing, manufacturing and selling endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products, and other medical products. In June 2014, Covidien plc was acquired by Medtronic for $42.9 billion in Cash and Stock. With its expanded portfolio of innovative products and services, this acquisition will allow Medtronic to reach more patients.

Product Portfolio:

Shiley Reinforced Oral/Nasal Endotracheal Tube: The Shiley oral/nasal endotracheal tube reinforced features a soft, flexible PVC tube with spiral-wound reinforcing wire designed to help reduce kinking.

The global endotracheal tube report would provide an access to an approx. 45+ market data table, 40+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The increasing prevalence of chronic respiratory diseases is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The lack of skilled professionals for endotracheal intubation is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Supply Chain
  • 5.3. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Regular Endotracheal Tube (Standard Tubes)*
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Reinforced/Armored Endotracheal Tube
  • 7.4. Preformed Endotracheal Tube
  • 7.5. RAE tube
  • 7.6. Double lumen Endotracheal Tube
  • 7.7. Other Specialty Endotracheal Tube
      • 7.7.1.1. Microlaryngeal Endotracheal Tube
      • 7.7.1.2. Laser Endotracheal Tube
      • 7.7.1.3. Others (Subglottic Suctioning Endotracheal Tubes)

8. By Intubation Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intubation Type
    • 8.1.2. Market Attractiveness Index, By Intubation Type
  • 8.2. Orotracheal*
      • 8.2.1.1. Introduction
      • 8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Nasotracheal

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Therapy*
      • 9.2.1.1. Introduction
      • 9.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Emergency Treatment
  • 9.4. Others

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user
  • 10.2. Hospitals*
      • 10.2.1.1. Introduction
      • 10.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Specialty Clinics
  • 10.4. Ambulatory Surgical Center
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intubation Type
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intubation Type
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intubation Type
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intubation Type
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intubation Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. ConvaTec Inc.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Bactiguard AB
  • 13.3. Teleflex Incorporated
  • 13.4. Medtronic Plc.(Covidien)
  • 13.5. Smith's Group plc.(Smiths Medical)
  • 13.6. ROYAX, S.R.O
  • 13.7. Medline Industries, Inc.
  • 13.8. Eakin Healthcare Group(Armstrong Medical Ltd)
  • 13.9. Venner Medical
  • 13.10. P3 Medical Limited

LIST NOT EXHAUSTIVE

14. Global Endotracheal Tube - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us